Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$305M |
| 2 |
Prologis
PLD
|
+$97.9M |
| 3 |
Carlisle Companies
CSL
|
+$29.2M |
| 4 |
Healthcare Realty
HR
|
+$28.7M |
| 5 |
Gaming and Leisure Properties
GLPI
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$91.2M |
| 3 |
Chevron
CVX
|
+$54.7M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$52.9M |
| 5 |
Microsoft
MSFT
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Industrials | 8.88% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
BOK Financial
BOKF
$8.84B
| $6.46M | ﹤0.01% |
72,674
+300
| +0.4% | +$26K |
|
|
MRTX
1127
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.44M | ﹤0.01% |
92,200
+900
| +1% | +$66.6K |
|
1128
LivaNova
LIVN
$4.55B
| $6.43M | ﹤0.01% |
126,719
+1,300
| +1% | +$77.2K |
|
1129
Signet Jewelers
SIG
$3.62B
| $6.43M | ﹤0.01% |
112,400
-11,600
| -9% | -$698K |
|
1130
Badger Meter
BMI
$3.8B
| $6.41M | ﹤0.01% |
69,400
+200
| +0.3% | +$18.6K |
|
1131
First Bancorp
FBP
$4.5B
| $6.41M | ﹤0.01% |
468,400
-16,000
| -3% | -$232K |
|
|
FL
1132
DELISTED
Foot Locker
FL
| $6.38M | ﹤0.01% |
205,100
-7,700
| -4% | -$246K |
|
1133
Vontier
VNT
$4.49B
| $6.38M | ﹤0.01% |
381,800
+2,100
| +0.6% | +$46.8K |
|
1134
EPR Properties
EPR
$4.75B
| $6.38M | ﹤0.01% |
177,788
+900
| +0.5% | +$42.5K |
|
1135
Avista
AVA
$3.24B
| $6.37M | ﹤0.01% |
171,800
+3,200
| +2% | +$134K |
|
1136
Beam Therapeutics
BEAM
$2.73B
| $6.35M | ﹤0.01% |
133,300
+4,800
| +4% | +$274K |
|
|
CALY
1137
Callaway Golf Company
CALY
$2.97B
| $6.33M | ﹤0.01% |
328,600
| – | – |
|
1138
NorthWestern Energy
NWE
$4.4B
| $6.33M | ﹤0.01% |
128,383
+900
| +0.7% | +$49.4K |
|
|
OSH
1139
DELISTED
Oak Street Health, Inc.
OSH
| $6.31M | ﹤0.01% |
257,200
+1,600
| +0.6% | +$42.3K |
|
1140
National Vision
EYE
$1.5B
| $6.3M | ﹤0.01% |
193,100
-2,500
| -1% | -$81.2K |
|
1141
Grand Canyon Education
LOPE
$3.79B
| $6.3M | ﹤0.01% |
76,600
-6,600
| -8% | -$572K |
|
1142
Belden
BDC
$5.4B
| $6.3M | ﹤0.01% |
104,900
-1,200
| -1% | -$76.3K |
|
|
PACW
1143
DELISTED
PacWest Bancorp
PACW
| $6.29M | ﹤0.01% |
278,473
+2,200
| +0.8% | +$59.2K |
|
|
AXNX
1144
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.29M | ﹤0.01% |
89,300
+2,000
| +2% | +$138K |
|
1145
Chegg
CHGG
$88.5M
| $6.29M | ﹤0.01% |
298,500
-19,100
| -6% | -$396K |
|
|
TMHC
1146
DELISTED
Taylor Morrison
TMHC
| $6.29M | ﹤0.01% |
269,560
-1,800
| -0.7% | -$46.7K |
|
1147
Denali Therapeutics
DNLI
$4.01B
| $6.26M | ﹤0.01% |
204,100
+2,700
| +1% | +$87.8K |
|
1148
Carter's
CRI
$1.43B
| $6.26M | ﹤0.01% |
95,500
-900
| -0.9% | -$68.9K |
|
1149
Fulton Financial
FULT
$4.69B
| $6.26M | ﹤0.01% |
396,000
+7,300
| +2% | +$118K |
|
1150
Walker & Dunlop
WD
$1.46B
| $6.25M | ﹤0.01% |
74,600
+1,000
| +1% | +$102K |
|
Similar funds
Swiss National Bank's Q3 2022 Portfolio in Review
As of Q3 2022, Swiss National Bank held 2,744 positions worth $140B, down 5.4% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 1.2%. Swiss National Bank opened 4 new positions and exited 30, leaving the 2,744-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2022 buy was Northrop Grumman: 639,945 shares worth $301M.
- Swiss National Bank added most to Prologis in Q3 2022, an estimated $97.9M increase.
- Swiss National Bank's biggest Q3 2022 reduction was Apple, cutting an estimated $102M.
- Swiss National Bank fully exited Duke Realty Corp. in Q3 2022, selling an estimated $91.2M.
- Swiss National Bank's ten largest holdings make up 26% of its $140B portfolio in Q3 2022.
- Swiss National Bank opened 4 new positions and closed 30 in Q3 2022.
- Swiss National Bank's portfolio value fell 5.4% quarter-over-quarter to $140B.
Based on Swiss National Bank's 13F filing for Q3 2022, filed 9 Nov 2022.